Breast Cancer Prevention Study: Are Healthy Women Put at Risk by Federally Funded Research? : Hearing Before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, Second Session, October 22, 1992

Portada
 

Comentarios de la gente - Escribir un comentario

No encontramos ningún comentario en los lugares habituales.

Otras ediciones - Ver todas

Términos y frases comunes

Pasajes populares

Página 37 - American Public Health Association 1015 15th Street NW Washington, DC 20005 (202) 789-5600...
Página 135 - Bartels. the administrative director of the Center for Biomedical Ethics at the University of Minnesota, outlined some of the concerns raised at an NIH/ELSI conference on genetic counseling in the United States.
Página 26 - Gail MH, Brinton LA, Byar DP, et aL Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
Página 5 - Committee, all witnesses before the committee will be sworn in. From time to time during the hearing, we will be inserting into the record, without objection, documents relevant to this matter. Before we begin, let me say to all of our witnesses that the full text of your written statements will be inserted in the hearing record.
Página 55 - My colleagues and I will be pleased to respond to your questions. [The prepared statement of Dr.
Página 11 - Shortly thereafter, in 1974, the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research was created.
Página 79 - A clinical trial to determine the worth of tamoxifen for preventing breast cancer.
Página 5 - Operations, all witnesses before the committee will be sworn in. From time to time during the hearing we will be inserting into the record, without objection, documents relevant to this matter. Before we begin, let me say to all of our witnesses that the full text of your written statements will be inserted into the hearing record.
Página 1 - Washington, DC. The subcommittee met, pursuant to notice, at 10:07 am, in room 2154, Rayburn House Office Building, Hon.
Página 26 - DC et al. Bone Mineral Density in Women with Breast Cancer Treated with Adjuvant Tamoxifen for at least Two Years. Breast Cancer Res Treat 1988) 12.279-302.

Información bibliográfica